Jlang,
I honestly had no knowledge of either Relief or Neurorx.
I just could not make sense of the putative MOA for Covid/immune dysfunction. I believe the explanation for aviptadil changed over time, giving me pause despite a number extolling its virtues,
Humanigen, Capricor, Mesoblast and Synairgen were stocks I held these until I learned more (cancer, Nash, neurological disease) and jumped into Leronlimab with both feet.
The science is something I can appreciate with a lot of work and a bit of help.
Management, good and bad, in small biotechs remains a bit opaque to me. Many competing claims. Quite a challenge to ferret out an objective truth.
I’ll my money and my faith in the science. Leronlimab is delayed but IMO won’t be denied.
I honestly had no knowledge of either Relief or Neurorx.
I just could not make sense of the putative MOA for Covid/immune dysfunction. I believe the explanation for aviptadil changed over time, giving me pause despite a number extolling its virtues,
Humanigen, Capricor, Mesoblast and Synairgen were stocks I held these until I learned more (cancer, Nash, neurological disease) and jumped into Leronlimab with both feet.
The science is something I can appreciate with a lot of work and a bit of help.
Management, good and bad, in small biotechs remains a bit opaque to me. Many competing claims. Quite a challenge to ferret out an objective truth.
I’ll my money and my faith in the science. Leronlimab is delayed but IMO won’t be denied.
8